Glass House Brands (GLAS) Construction in Progress (2021 - 2024)
Glass House Brands (GLAS) posted quarterly Construction in Progress of $1.0 million for Q1 2024, down 89.91% quarter-over-quarter from $10.2 million in Q4 2023.
Glass House Brands (GLAS) Construction in Progress (2021 - 2024) Analysis & Trends
Glass House Brands (GLAS) has reported Construction in Progress for 4 consecutive years, with $1.0 million the latest figure, recorded in Q1 2024.
- In Q1 2024, Construction in Progress changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2024 stood at $1.0 million (changed N/A YoY), while the FY2023 annual figure was $10.2 million, changed N/A from the prior year.
- Construction in Progress retreated to $1.0 million in Q1 2024 per GLAS's latest filing, from $10.2 million in the prior quarter.
- Across five years, Construction in Progress topped out at $23.4 million in Q1 2022 and bottomed at $1.0 million in Q1 2024.
- Historically, Construction in Progress has averaged $11.6 million across 4 years, with a median of $11.0 million in 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Glass House Brands | 830.21 Mn | 811.66 Mn | 15.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 10.17 Mn |
| Mar 31, 2022 | 23.37 Mn |
| Dec 31, 2021 | 11.87 Mn |